Numerion Labs, headquartered in San Francisco, CA, USA, specializes in AI-based drug discovery services. The company employs a world-class team of scientists and engineers to redefine how small-molecule drugs are discovered using artificial intelligence.
Subscribe to see Numerion Labs’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Numerion Labs is an ai/ml company headquartered in United States. Its most recent funding round raised $19.8M in March 2026. Xcout tracks 12 named people at Numerion Labs, including Stephen Worland (Chief Executive Officer).
6 more named people on record for Numerion Labs, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $19.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Numerion Labs's closest competitors — see the full list of competitors and alternatives →
AION Labs is a venture studio headquartered in Rehovot, Israel. It is dedicated to building and investing in startups that leverage AI to revolutionize drug discovery and development, connecting pharma R&D with new AI, technology, and scientific innovation.
Isomorphic Labs is a drug discovery company that uses predictive and generative artificial intelligence to model biological phenomena and design novel medicines. Building upon the AlphaFold system, the company develops AI-driven tools aimed at accelerating scientific research and treating devastating diseases.
Radical Numerics is headquartered in Menlo Park, California. It operates as a next-generation AI lab focused on general biological intelligence.
Aizon (operating as Bigfinite Inc.) is a software-as-a-service company headquartered in San Francisco, United States. It provides artificial intelligence-powered software solutions targeted at intelligent GxP manufacturing.
Azulene Labs builds physics-grounded AI foundation models for chemistry to transform computational chemistry workflows with predictive and precise physics-powered AI.
B12 Labs provides an AI-powered software platform that automates and accelerates chemical synthesis for the pharmaceutical and biotechnology industries. Its tools assist researchers with retrosynthesis planning, reaction condition optimization, and the generation of execution-ready protocols for lab automation equipment.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.